These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7904031)

  • 21. Sulindac in familial adenomatous polyposis.
    Tonelli F; Valanzano R
    Lancet; 1993 Oct; 342(8879):1120. PubMed ID: 8105347
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effects of sulindac on the pathology of colorectal remnant polyps of familial adenomatous polyposis (FAP) patients].
    Li J; Lv YM; Jin Z; Cui RL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):371-3. PubMed ID: 16086054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients.
    Koornstra JJ; Rijcken FE; Oldenhuis CN; Zwart N; van der Sluis T; Hollema H; deVries EG; Keller JJ; Offerhaus JA; Giardiello FM; Kleibeuker JH
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1608-12. PubMed ID: 16030090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of suindac in the treatment of familial adenomatous polyposis coli].
    Landauer S; Halimi C; Caulin C; Bergmann JF
    Therapie; 1999; 54(6):675-82. PubMed ID: 10709439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sulindac--drug therapy for familial adenomatous polyposis?].
    Zundler J; Walker S
    Med Klin (Munich); 1993 Jan; 88(1):35-8, 49. PubMed ID: 8382335
    [No Abstract]   [Full Text] [Related]  

  • 26. Sulindac plus erlotinib for familial adenomatous polyposis.
    Baker H
    Lancet Oncol; 2016 May; 17(5):e183. PubMed ID: 27051970
    [No Abstract]   [Full Text] [Related]  

  • 27. Sulindac and polyp regression.
    Giardiello FM
    Cancer Metastasis Rev; 1994 Dec; 13(3-4):279-83. PubMed ID: 7712590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rectal micropolyps after total colectomy in familial polyposis. Efficacy of sulindac].
    Charneau J; D'Aubigny N; Burtin P; Person B; Boyer J
    Gastroenterol Clin Biol; 1990; 14(2):153-7. PubMed ID: 2158470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulindac-associated ulcerative pouchitis in familial adenomatous polyposis.
    Bertoni G; Sassatelli R; Bedogni G; Nigrisoli E
    Am J Gastroenterol; 1996 Nov; 91(11):2431-2. PubMed ID: 8931434
    [No Abstract]   [Full Text] [Related]  

  • 30. Adverse effects of sulindac used for prevention of colorectal cancer.
    Ishikawa H; Akedo I; Suzuki T; Narahara H; Otani T
    J Natl Cancer Inst; 1997 Sep; 89(18):1381. PubMed ID: 9308710
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients.
    Quast DR; Schneider R; Burdzik E; Hoppe S; Möslein G
    Fam Cancer; 2016 Jan; 15(1):31-40. PubMed ID: 26275868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenomas of the ampulla of vater in familial adenomatous polyposis: Christian Theodore responds.
    Theodore C
    Gastroenterology; 2004 Feb; 126(2):628-9. PubMed ID: 14765399
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of long-term sulindac therapy on colonic polyposis.
    Rigau J; Piqué JM; Rubio E; Planas R; Tarrech JM; Bordas JM
    Ann Intern Med; 1991 Dec; 115(12):952-4. PubMed ID: 1659272
    [No Abstract]   [Full Text] [Related]  

  • 34. Dietary putrescine reduces the intestinal anticarcinogenic activity of sulindac in a murine model of familial adenomatous polyposis.
    Ignatenko NA; Besselsen DG; Roy UK; Stringer DE; Blohm-Mangone KA; Padilla-Torres JL; Guillen-R JM; Gerner EW
    Nutr Cancer; 2006; 56(2):172-81. PubMed ID: 17474863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic polymorphisms of flavin monooxygenase 3 in sulindac-induced regression of colorectal adenomas in familial adenomatous polyposis.
    Hisamuddin IM; Wehbi MA; Schmotzer B; Easley KA; Hylind LM; Giardiello FM; Yang VW
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2366-9. PubMed ID: 16214918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphisms of human flavin monooxygenase 3 in sulindac-mediated primary chemoprevention of familial adenomatous polyposis.
    Hisamuddin IM; Wehbi MA; Chao A; Wyre HW; Hylind LM; Giardiello FM; Yang VW
    Clin Cancer Res; 2004 Dec; 10(24):8357-62. PubMed ID: 15623613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.
    Samadder NJ; Neklason DW; Boucher KM; Byrne KR; Kanth P; Samowitz W; Jones D; Tavtigian SV; Done MW; Berry T; Jasperson K; Pappas L; Smith L; Sample D; Davis R; Topham MK; Lynch P; Strait E; McKinnon W; Burt RW; Kuwada SK
    JAMA; 2016 Mar 22-29; 315(12):1266-75. PubMed ID: 27002448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors.
    Giardiello FM; Offerhaus JA; Tersmette AC; Hylind LM; Krush AJ; Brensinger JD; Booker SV; Hamilton SR
    Gut; 1996 Apr; 38(4):578-81. PubMed ID: 8707091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cure crusader. How a cancer patient waged a determined quest for a medical miracle--and may still achieve it.
    Thompson D
    Time; 1999 Oct; 154(15):72-3. PubMed ID: 10620933
    [No Abstract]   [Full Text] [Related]  

  • 40. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis.
    Chiu CH; McEntee MF; Whelan J
    Cancer Res; 1997 Oct; 57(19):4267-73. PubMed ID: 9331087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.